• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Discovery shows how tuning the immune system may enhance vaccines and ease disease

Bioengineer by Bioengineer
July 7, 2021
in Health
Reading Time: 4 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A metabolic control pathway that regulates T follicular helper cells offers targets for drugs to stimulate the adaptive immune response

IMAGE

Credit: St. Jude Children’s Research Hospital

Immunologists at St. Jude Children’s Research Hospital have identified a biological pathway that selectively controls how key immune cells, called T follicular helper cells, mature into functional components of the immune system.

The finding offers the promise of developing drugs to activate the metabolic pathway to enhance the effectiveness of vaccines, including those that protect against COVID-19. Such medications could stimulate the immune system to respond more vigorously following immunization to produce more antibodies against a virus or bacterium.

The work also lays the foundation for drugs that dial down the pathway to alleviate autoimmune diseases such as lupus. In such disorders, an overactive immune system produces antibodies that attack the body’s own tissues.

Led by Hongbo Chi, Ph.D. of the Department of Immunology, the researchers published their findings today in Nature.

Regulating the adaptive immune response

Chi and colleagues identified a metabolic control pathway that selectively regulates the development of specialized immune cells in the adaptive immune system. These cells are called T follicular helper cells.

The adaptive immune system is so named because when the body is infected by viruses or bacteria, it learns to target and attack them. T follicular helper cells activate the component of the adaptive immune system called humoral immunity. While humoral immunity attacks invaders circulating outside cells largely via the generation of antibodies, the other adaptive immune system component, cellular immunity, targets invaders inside infected cells.

In their experiments, the researchers sought to discover whether a metabolic control pathway existed that modified the T follicular helper cells to activate them. When such cells are activated, they help antibody-producing cells, called B cells, to mature and to generate infection-fighting antibodies.

Discovering a key pathway

To discover a possible control pathway, Chi and his colleagues used genetic techniques to delete in the T cells multiple enzymes known to be elements of such metabolic control pathways. Then, the scientists introduced the deletion-engineered T cells into mice followed by infection with a virus and tested whether the T cells lacking the enzyme were functional.

Their experiments revealed that one metabolic control pathway, called the CDP-ethanolamine pathway, selectively regulated the T follicular helper cells.

“This finding was a big surprise,” Chi said. “First of all, this pathway was considered to have a housekeeping function leading to the production of building blocks for the cell membrane. But we discovered that it has a major signaling function. And secondly, we were surprised that this pathway–and not other parallel pathways of this type–was the only one involved in regulating T follicular helper cells.”

As a complementary method to determine if the pathway selectively regulated the T follicular helper cells, the researchers deleted each of the key enzymes they identified in the CDP-ethanolamine pathway. They found that deletion of these enzymes, but not those of other parallel regulatory pathways, selectively impaired development of the T follicular helper cells, but not overall immune function.

Importantly, said Chi, those key enzymes could be targets for drugs that either enhance or inhibit the pathway, and thus the activity of the T cells.

“We are now exploring whether we can enhance the effectiveness of vaccines by using drugs that activate the pathway, to help these T cells mobilize the immune system to generate antibodies in response to a vaccine,” he said.

“On the other hand, to treat autoimmune disease, we’re interested in developing new ways to inhibit this pathway,” he said. “This approach is promising because we know that such activation or inhibition is highly selective for T follicular helper cells and would not affect other immune functions.”

The researchers are also delving into the structural mechanisms by which the enzymes work–insights that could offer such drug targets, Chi said.

###

Authors and funding

Guotong Fu, Ph.D., St. Jude Immunology, is the first author. The other St. Jude authors are Clifford Guy, Nicole Chapman, Gustavo Palacios, Jun Wei, Peipei Zhou, Lingyun Long, Yong-Dong Wang, Chenxi Qian, Yogesh Dhungana, Hongling Huang, Anil KC, Hao Shi, Sherri Rankin, Scott Brown, Amanda Johnson, Randall Wakefield, Camenzind Robinson, Jiyang Yu and Suzanne Jackowski. Additional authors are Xueyan Liu, University of New Orleans, and Anthony Sheyn, University of Tennessee Health Science Center.

The research was supported in part by the National Institutes of Health (AI105887, AI131703, AI140761, AI150241, AI150514, CA221290), Lupus Research Alliance and ALSAC, the fundraising and awareness organization of St. Jude.

Media Contact
Katy Hobgood
[email protected]

Original Source

https://www.stjude.org/media-resources/news-releases/2021-medicine-science-news/discovery-shows-how-tuning-the-immune-system-may-enhance-vaccines-and-ease-disease.html

Related Journal Article

http://dx.doi.org/10.1038/s41586-021-03692-z

Tags: Cell BiologyImmunology/Allergies/AsthmaMedicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

Metabolism’s Impact on Enzyme Evolution Over Millennia

Metabolism’s Impact on Enzyme Evolution Over Millennia

July 10, 2025
blank

Tackling Toxicity of China’s Fine Particulates

July 10, 2025

Targeted Adipose Changes in Obesity, Weight Loss

July 10, 2025

Bowhead Whale Waste Boosts Arctic Algal Toxins

July 10, 2025
Please login to join discussion

POPULAR NEWS

  • Zheng-Rong Lu

    Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    75 shares
    Share 30 Tweet 19
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    72 shares
    Share 29 Tweet 18
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    69 shares
    Share 28 Tweet 17
  • New Organic Photoredox Catalysis System Boosts Efficiency, Drawing Inspiration from Photosynthesis

    54 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Catalytic Cycle Revolutionizes Crude Hydrogen Handling

Unraveling the Chemical Complexity of Plastics

Hidden Genetic Interactions Drive Plant Trait Changes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.